Cargando…

Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience

Background: Severe eosinophilic asthma decreases lung function and causes worsen symptoms, often forcing recurrent maintenance corticosteroid use. The aim of our real-life study was to evaluate the effectiveness of an add-on treatment with benralizumab in patients with severe eosinophilic asthma, pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scioscia, Giulia, Carpagnano, Giovanna Elisiana, Quarato, Carla Maria Irene, Lacedonia, Donato, Santamaria, Sonia, Soccio, Piera, Depalo, Annarita, Fuso, Paolo, Foschino Barbaro, Maria Pia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928350/ https://www.ncbi.nlm.nih.gov/pubmed/33679414 http://dx.doi.org/10.3389/fphar.2021.631660

Ejemplares similares

The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study
por: Scioscia, Giulia, et al.
Publicado: (2020)

Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
por: Scioscia, Giulia, et al.
Publicado: (2023)

A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2019)

Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype
por: Lacedonia, Donato, et al.
Publicado: (2017)

EVs-miRNA: The New Molecular Markers for Chronic Respiratory Diseases
por: Soccio, Piera, et al.
Publicado: (2022)

Omalizumab as add‐on therapy in a patient with severe asthma and OSA
por: Scioscia, Giulia, et al.
Publicado: (2020)

Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2022)

Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2022)

Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study
por: Campisi, Raffaele, et al.
Publicado: (2023)

MicroRNA expression profile during different conditions of hypoxia
por: Lacedonia, Donato, et al.
Publicado: (2018)

Transthoracic ultrasound sign in severe asthmatic patients: a lack of “gliding sign” mimic pneumothorax
por: Del Colle, Anna, et al.
Publicado: (2019)

MiRNA and Exosomal miRNA as New Biomarkers Useful to Phenotyping Severe Asthma
por: Soccio, Piera, et al.
Publicado: (2023)

Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2020)

Obstructive Sleep Apnea: A Look towards Micro-RNAs as Biomarkers of the Future
por: Moriondo, Giorgia, et al.
Publicado: (2022)

Adaptive immunity in different CT patterns of active tuberculosis and possible variability according to patients' geographic provenience
por: Scioscia, Giulia, et al.
Publicado: (2022)

Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab
por: Carpagnano, Giovanna E, et al.
Publicado: (2019)

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2020)

Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
por: Lacedonia, Donato, et al.
Publicado: (2021)

Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
por: Resta, Emanuela, et al.
Publicado: (2022)

Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2018)

Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis
por: Moriondo, Giorgia, et al.
Publicado: (2022)

Searching for airways biomarkers useful to identify progressive pulmonary fibrosis
por: Soccio, Piera, et al.
Publicado: (2023)

Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression
por: Pelaia, Corrado, et al.
Publicado: (2021)

The Role of Transthoracic Ultrasound in the Study of Interstitial Lung Diseases: High-Resolution Computed Tomography Versus Ultrasound Patterns: Our Preliminary Experience
por: Lacedonia, Donato, et al.
Publicado: (2021)

Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real-life study
por: Santomasi, Carla, et al.
Publicado: (2023)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
por: Portacci, Andrea, et al.
Publicado: (2023)

Real life experience of molnupiravir as a treatment of SARS-CoV-2 infection in vaccinated and unvaccinated patients: a letter on its effectiveness at preventing hospitalization
por: Scioscia, Giulia, et al.
Publicado: (2022)

Microparticles in sputum of COPD patients: a potential biomarker of the disease?
por: Lacedonia, Donato, et al.
Publicado: (2016)

Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy
por: Pelaia, Corrado, et al.
Publicado: (2021)

Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis
por: Lacedonia, Donato, et al.
Publicado: (2021)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2021)

Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub‐phenotypes of response identified by cluster analysis
por: Di Bona, Danilo, et al.
Publicado: (2021)

Inhaled Medications in Chronic Respiratory Diseases: Analysis of Real-Life Use in Puglia (Apulia), Italy
por: Scioscia, Giulia, et al.
Publicado: (2023)

Tocilizumab and liver injury in patients with COVID-19
por: Serviddio, Gaetano, et al.
Publicado: (2020)

Surgical Mask and N95 in Healthcare Workers of Covid-19 Departments: Clinical and Social Aspects
por: Gelardi, Matteo, et al.
Publicado: (2020)

COVID-19 Pneumonia: The Great Ultrasonography Mimicker
por: Lacedonia, Donato, et al.
Publicado: (2021)

Chylothorax found in a patient with COVID‐19
por: Satriano, Francesco, et al.
Publicado: (2022)

Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease
por: Dragonieri, Silvano, et al.
Publicado: (2016)

Chest Imaging in the Diagnosis and Management of Pulmonary Tuberculosis: The Complementary Role of Thoraci Ultrasound
por: Rea, Gaetano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_21h7d5ehbfa37gmlnf0sb2ikmh